Vaccination key to preventing a devastating flu season
An expert weighs in on the factors driving influenza cases in 2023 and how pharmacists can encourage vaccination in all patients.
ATAGI highlights progress amid resurgent diseases
ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2
How to talk about smoking cessation in priority populations
Pharmacists can provide important information and support, recommend suitable over-the-counter products to help patients quit smoking.
The female pharmacist striving to improve disability visibility
Ahead of International Women's Day, this pharmacist explains how she challenges perceptions of beauty and the healthcare workforce.
Aus CVD risk: the Australian cardiovascular disease risk calculator
The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.













